Concepedia

An Open-Label Clinical Trial Evaluating Safety and Pharmacokinetics of Two Dosing Schedules of Panitumumab in Patients with Solid Tumors

Joe Stephenson, Charles Gregory, Howard A. Burris, Tim Larson, Udit Verma, Allen Lee Cohn, Jeffrey Crawford, Roger B. Cohen, Julie Martin, Peggy Lum,

Clinical Colorectal Cancer · 2009 · 42 citations · 11 references

DOI

Concepts

References

11

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer

Eric Van Cutsem, Marc Peeters, Salvatore Siena et al. · Journal of Clinical Oncology · 2007 · 2K citations

, , +14

High Incidence of Cetuximab-Related Infusion Reactions in Tennessee and North Carolina and the Association With Atopic History

Bert H. O’Neil, Robert M. Allen, David R. Spigel et al. · Journal of Clinical Oncology · 2007 · 351 citations · Full text

, , +14

Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.

Xiaodong Yang, Xiao‐Chi Jia, J R Corvalán et al. · PubMed · 1999 · 330 citations

, , +16

Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer

Eric K. Rowinsky, Garry Schwartz, Jared Gollob et al. · Journal of Clinical Oncology · 2004 · 328 citations · Full text

, , +17